FDA Investigator Graham N Giesen

Graham N Giesen has conducted inspections on 64 sites in 3 countries as of 14 Jan 2013. See below for a list of the FDA enforcement documents resulting from those inspections.

Investigator Details

Number of Inspected Sites:
64
Last Inspection Date:
14 Jan 2013
Investigator Role:
FDA Investigator
Redica ID:
100008577
Countries of Inspections:
United States of America, Ireland, United Kingdom of Great Britain and Northern Ireland
FDA Investigators that have inspected at least one site in common with Graham N Giesen:
Aaron J Poloni, Abigail A Andersen, Adrian Rodriguez, Alan D Grupe, Alexander M Kay, Alexandria L Capuano, Alicia M Weitzel, Althea A Williams, Arie R Dyk, Ashleigh P Barkans, Ashley A Mutawakkil, Barbara J Rincon, Beau R Lamb, Brenda L Reihing, Bruce R Burrell, Bryan J Love, Bryce E Mansfield, Casey L Hamblin, Catherine J Laufmann, CDR Sean T Creighton, Celeta S Coves, Celia L Hutchinstein, Celia L Silverstein, Christine I Shaw, Christopher S Genther, Claudette D Brooks, Creighton T Tuzon, Crystal A Harlan, Cynthia L Gorveatt, Dan G Eisenbrey, David A Pettenski, Deborah A Nebenzahl, Dennis G Kawabata, Devon M Shoop, Dolores Harper, Edward E Lockwood (EEL), Edward R Kay, Elizabeth S Howell, Elmina E Akwo, Elmina E Mboh, Eric C Milstead, Eric W Anderson, George T Allen, Jr, Gerard Pde Leon, Gregson A Joseph, Harmon M Blanch, Hugh A Grimoldby, J Elkins, James D Hildreth, James R Fleckenstein, James S Cartwright, Janice Chellis, Jeannine K Wooten, Jeffrey J Leclair, Jeffrey N Gerdes, Jesse A Vazquez, Jessica B Clark, Jessica L Johnson, Jinkee Mvila Binayug, John E Emmert, John W Banks, Jonathan T Little, Jude C Dikes, Julia E Chervoni, Julian C Hanson, Karen S Anthony, Karlton T Watson, Katherine L Arnold, Kimberly Lewandowski Walker, Kurt M Hafer, Laura E Hausch, Leonard H Lavi, Linda A Gregory Duty, Lisa K Capron, Lori J Jennings, Lori J Silverstein, Lorna F Jones, Marc R Dickens, Margo C Jones, Maria Pkelly Doggett, MBA, Mark E Imsland, Mark E Moen, Mark W Babbitt, Michael A Taylor, Michael Govro, Michael S Hudson, Msdap Gonzlezk, Nancy A Saxenian Emmons, Nancy E Doyle, Neil J Traaen, Nichole A Broadhacker, Paul F Rader, Paul M Kawamoto, Paul Rader, Peter T Regan, Philip E Ake, Phillip M Pontikos, Rebecca T Davis, Richard Jay Tucker, RS, Robert D Tollefsen, Robert F Hennes, Rocco C Black, Ronald T Weber, S Lori Brown, PhD MPH, Scott A Nabe, Scott R Nichols, PhD, Scott W Fox, Shannon A Lowe, Sharon I Gundersen, Sherri N Rohlf, MD, Sonia R Peterson, Staci G Mcallister, Stanley B Eugene, BS, BME, Stephanie A Jameson, Stephanie L Kelly, Stephen R Souza, Tara A Gray, Tara M Pianko, Terri E Gibson, Thomas C Mclean, CFS, Timothy S Williamson, Tracy K Li, Vanessa Y Jacobs, Victor Spanioli, Vitaliy N Guyvan, Xiaojun Yan

Graham N Giesen's Documents

Publish Date Document Type Title
September, 2011 FDA 483 Neurocybernetics Inc - Form 483, 2011-09-16
December, 2010 FDA 483 Biodynamics Corporation - Form 483, 2010-12-03
September, 2010 FDA 483 Generic Medical Devices, Inc. - Form 483, 2010-09-09
October, 2011 FDA 483 I-Flow Corporation d.b.a. AcryMed, Inc. - Form 483, 2011-10-28
May, 2012 FDA 483 InBios International, Inc. - Form 483, 2012-05-04
April, 2012 FDA 483 Pedigo Products, Inc. - Form 483, 2012-04-18
April, 2012 FDA 483 Parks Medical Electronics, Inc - Form 483, 2012-04-20
December, 2009 FDA 483 Tricol Biomedical, Inc. - Form 483, 2009-12-11
February, 2012 FDA 483 Synergy Health Ireland Ltd. - Form 483, 2012-02-15
September, 2010 FDA 483 Response Generic Medical Devices, Inc. - Form 483R, 2010-09-27
April, 2012 FDA 483 Generic Medical Devices, Inc. - Form 483, 2012-04-25
April, 2012 FDA 483 Response Generic Medical Devices, Inc. - Form 483R, 2012-05-14
January, 2012 FDA 483 Biodynamics Corporation - Form 483, 2012-01-27
October, 2011 FDA 483 ACUTE Innovations, LLC - Form 483, 2011-10-21
November, 2009 FDA 483 Response Willamette Shelling Inc - Form 483R, 2009-11-23
December, 2011 FDA 483 Philips Ultrasound, Inc. - Form 483, 2011-12-09
February, 2012 EIR Synergy Health Ireland Ltd. - EIR, 2012-02-15
November, 2009 FDA 483 Willamette Shelling Inc - Form 483, 2009-11-20

Experience Redica Systems’ NEW investigator profiles and dashboards

Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:

  • Total inspections conducted
  • 483 rate
  • OAI rate
  • Warning Letter rate
  • Inspections by Industry, Scope, and Inspection Reason
  • And much more

Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.

FDA Investigator Profile Icon

Talk to sales to access our investigator profiles

Loading...

Investigator Profiles Are Just the Tip of the Iceberg

Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:

Inspection Intelligence

  • Pre-Approval Inspection (PAI) trends
  • The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
  • Latest 483s: see what the trends are across all FDA Investigators
  • CFR Heatmap: Citations aggregated by Subpart by Year

Vendor Intelligence

  • Full inspection histories for your vendors down to the specific site level
  • All of the functionality mentioned above but isolated to just your vendors

Regulatory Intelligence

  • Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
  • All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more